跳至主要内容
临床试验/NCT06726603
NCT06726603已完成不适用

Trends in Pregnancy Outcomes Beyond 20 Weeks Gestational Age in Assisted Reproductive Technology Conceived Pregnancies in BC

University of British Columbia0 个研究点目标入组 1,000 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000
主要终点
Pregnancy complications beyond 20 weeks gestation age

研究概览

简要总结

Examining outcomes beyond 20 weeks gestational age in pregnancies conceived by ART compared to spontaneously conceived pregnancies

  1. To determine if a difference in outcomes for pregnancies beyond 20 weeks gestational age exists between ART-treated and spontaneous conception populations in BC. Specifically, the investigators will examine the prevalence for gestational diabetes, gestational hypertension, premature deliveries, low birth weight, miscarriages, maternal length of stay in hospital, NICU admissions, APGAR scores<6, and arterial cord gas pH<7.
  2. To examine the trend of outcomes beyond 20 weeks GA associated with ART by calendar year from March 2008 to April 2018.

The research literature from other study populations suggest the prevalence of pregnancy complications are higher amongst women with ART-treated deliveries. Specifically, there is a trend towards higher rates of gestational diabetes, pregnancy induced hypertension, premature deliveries, low birthweight deliveries, perinatal deaths and maternal length of stay in hospital after delivery. The challenge lies in determining the degree of difference and the trend.

Given the relatively older age of conception in BC, the investigators hypothesize that the aforementioned complications may in fact be higher in both the spontaneous conception and ART-treated groups. That being said, the investigators suspect the ART group is likely to still have a higher rates of gestational diabetes, hypertension, premature deliveries, low birthweight, and miscarriages.

详细描述

The investigators intend to conduct a retrospective cohort study examining differences in pregnancy outcomes after 20 weeks GA in ART-treated versus fertile women.

The study population will consist of women in BC with in-province deliveries occurring between March 1 2008 and April 31 2018 that resulted in singleton live birth or fetal death at >20 weeks. Only fertile women conceiving their index pregnancy by assisted reproductive technology (ART) will be included. Multiparous women and women with multiple gestation deliveries will be excluded. Also, any women missing data including gravida, parity, age, date of birth, neonatal birth weight, neonatal APGARs, neonatal live birth versus stillbirth Data will be collected from the perinatal services BC database, following approval. A biostatistician will be employed to help utilize the data requested.

Obstetric and Fetal outcome measures of prematurity (<37 weeks GA), low birthweight (<2500g), small for gestational age (in live births), perinatal death (fetal death >20 weeks to death of newborn up to 7 days post-delivery), prolonged maternal length of stay in hospital following delivery (>3 days), and maternal hospital readmission (rehospitalization 0-60 days after delivery plus emergency department of observation stay visits 0-7 days after delivery), gestational diabetes (insulin and non-insulin dependent), gestational hypertension (>140/90 after 20 weeks GA), pre-eclampsia HELLP Syndrome, Postpartum infection, admission to NICU, APGAR score <6, cord arterial gas pH <7. Chi square statistics will be used to evaluate statistical differences in binary outcomes among fertile and ART-treated groups while ANOVA tests will be implemented to evaluate differences in continuous outcomes. Multivariable models will be adjusted for potential confounders including maternal age (30, 31-34, 35-37, 38-40, >40), smoking (yes/no), chronic hypertension (yes/no), pre-pregnancy diabetes (type 1 and type 2), pre-pregnancy BMI equal to or greater than 30.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
Female
接受健康志愿者

入选标准

  • Women in BC with in-province deliveries occurring between March 1 2008 and April 31 2018 that resulted in singleton live birth or fetal death at >20 weeks
  • Only fertile and women conceiving their index pregnancy by assisted reproductive technology (ART) will be included.

排除标准

  • Multiparous women and women with multiple gestation deliveries will be excluded
  • any women missing data including gravida, parity, age, date of birth, neonatal birth weight, neonatal APGARs, neonatal live birth versus stillbirth will be excluded

结局指标

主要结局

Pregnancy complications beyond 20 weeks gestation age

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

Pre-eclampsia

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

Blood pressure of 140/90 mmHg or higher and symptoms or signs of ongoing damage to internal organs

Gestational hypertension

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

Blood pressure of 140/90 mmHg or higher and no symptoms or signs of ongoing damage to internal organs

HELPP syndrome

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

Evidence of hemolysis, elevated liver enzymes, Low platelets

Low birth weight of infant

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

\<2500 grams

small for gestational age

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

A weight below the 10th percentile for the gestational age.

Gestational diabetes

时间窗: This outcome is measured from point at which patient is 20 weeks gestational age to one month postpartum

Low APGAR score

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum, depends on delivery timing

AGPAR score less than 6 at time of live birth delivery

Cord arterial pH< 7

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

At time of delivery of neonate

NICU admission

时间窗: From point at which patient is 20 weeks gestational age to one month postpartum

Admission to NICU

perinatal death

时间窗: From point at which patient is 20 weeks gestational age to 7 days post-delivery

fetal death \>20 weeks to death of newborn up to 7 days post-delivery

次要结局

  • Maternal re-admission to hospital(From delivery to 60 days after maternal delivery)
  • Maternal postpartum infection(from delivery to one month postpartum)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Bedaiwy

Principle Investigator

University of British Columbia

相似试验